Jul 28, 2024, 08:13
Rahul Banerjee: How different BCMA Treatment fare in Multiple myeloma by Matthew J Rees, Vincent Rajkumar et al
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X:
“Great Blood Cancer work by , et al! How different BCMA Treatment fare in Multiple myeloma. Zooming in on 4th figure in Bob’s summary: for true EMD (visceral), MRD-neg BMBx not enough. Scan often, and I reach early for tal +/- pom after any hint of BCMA CAR-T failure here.”
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Autors: Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, Mohammed E Elhaj, Arwa Bohra, Radhika Bansal, Sikander Ailawadhi, Ricardo Parrondo, Saurabh Chhabra, Amit Khot, Suzanne Hayman, Angela Dispenzieri, Francis Buadi, David Dingli, Rahma Warsame, Prashant Kapoor, Morie A Gertz, Eli Muchtar, Taxiarchis Kourelis, Wilson Gonsalves, S Vincent Rajkumar, Yi Lin, Shaji Kumar
Source: Rahul Banerjee/X
Abiola Bolarinwa
Amit Khot
Angela Dispenzieri
Arwa Bohra
Aytaj Mammadzadeh
blood cancer
cancer
David Dingli
Eli Muchtar
Francis Buadi
Matthew J Rees
Mohammed E Elhaj
Morie A Gertz
OncoDaily
Oncology
Prashant Kapoor
Radhika Bansal
Rahma Warsame
Rahul Banerjee
Ricardo Parrondo
S Vincent Rajkumar
Saurabh Chhabra
Shaji Kumar
Sikander Ailawadhi
Suzanne Hayman
Taxiarchis Kourelis
Wilson Gonsalves
Yi Lin
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19